4
Changes in Ownership
Tyra Biosciences, Inc. Filed Acc 0000950170-25-007426
Director sold 25,041 shares at an average $16.36 ($409,645)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Kjellson Nina S Director | 2025-01-16 | Sale | −6,944 | $16.29 | $113,097 | 3,724,221 | I: show line 1 in the form |
| Kjellson Nina S Director | 2025-01-16 | Sale | −835 | $16.29 | $13,600 | 447,857 | I: show line 2 in the form |
| Kjellson Nina S Director | 2025-01-17 | Sale | −12,808 | $16.40 | $210,052 | 3,711,413 | I: show line 3 in the form |
| Kjellson Nina S Director | 2025-01-17 | Sale | −461 | $16.40 | $7,560 | 447,396 | I: show line 4 in the form |
| Kjellson Nina S Director | 2025-01-21 | Sale | −3,993 | $16.36 | $65,336 | 3,707,420 | I: show line 5 in the form |
| Open-market sales · 25,041 sh · avg $16.36 · $409,645 | |||||||
Loading xslF345X05/ownership.xml…